Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,405.20
(
-2.38%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
0.00%
)
Bitcoin
66,246.60
(
-0.14%
)
News Focus
News Focus
Post# of 19309
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

floblu14

Send PM Follow Ignore
Followers 24
Posts 3962
Boards Moderated 0
Alias Born 07/20/2006

floblu14

Re: Pre_Clinical post# 4267

Monday, 07/23/2007 9:24:21 PM

Monday, July 23, 2007 9:24:21 PM

Post# of 19309
Earlier I had reported on this patent application dated April 26, 07 - which might help to explain GTC's technical advantage -

ANTIBODIES WITH ENHANCED ANTIBODY-DEPENDENT CELLULAR CYTOXICITY ACTIVITY, METHODS OF THEIR PRODUCTION AND USE

http://v3.espacenet.com/textdes?DB=EPODOC&IDX=WO2007048077&F=0&QPN=WO2007048077

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today